9
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Aspects of osseous, peritoneal and renal handling of bisphosphonate during peritoneal dialysis: a methodological study

&
Pages 327-337 | Received 27 Nov 1995, Accepted 05 Feb 1996, Published online: 08 Jul 2009

References

  • Joffe P, Heaf J G, Hyldstrup L. Osteocalcin: a non-invasive index of metabolic bone disease in patients treated by continuous ambulatory peritoneal dialysis. Kidney Int 1994; 46: 838–46
  • Joffe P, Heaf J G, Jensen C. Can bone histomorphometry be predicted by clinical assessment and non-invasive techniques in peritoneal dialysis?. Miner Electrolyte Metab 1996, In press
  • Hyldstrup L, McNair P, Ring P, Henriksen O. Studies on diphosphonate kinetics. Part II: Whole body uptake rate during constant infusion—a refined index of bone metabolism. Eur J Nucl Med 1987; 12: 585–8
  • Joffe P, Hyldstrup L, Heaf J G, Poedenphant J, Henriksen J H. Bisphosphonate kinetics in patients undergoing continuous ambulatory peritoneal dialysis: relations to dynamic bone histomorphometry, osteocalcin and parathyroid hormone. Am J Nephrol 1992; 12: 419–24
  • Joffe P, Henriksen J H. Bidirectional transport of albumin in continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl 1995; 10: 1725–32
  • Hyldstrup L, McNair P, Ring P, Henriksen O. Studies on diphosphonate kinetics. Part I: Evaluation of plasma elimination curves during 24h. Eur J Nucl Med 1987; 12: 581–4
  • Henriksen J H. Whole-body microvascular permeability of small molecules in man: clinical aspects, basis concepts and limitations of the single injection technique. Scand J Clin Lab Invest 1985; 45: 509–13
  • Simonsen L, Bulow J, Madsen J. Adipose tissue metabolism in humans determined by vein catheterization and microdialysis techniques. Am J Physiol 1994; 266: E357–65
  • Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271–4
  • Krediet R T, Arisz L. Fluid and solute transport across the peritoneum during continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1989; 9: 15–25
  • Fugleberg S, Graff J, Joffe P, Løkkegaard H, Feldt-Rasmussen B, Fogh-Andersen N, Nielsen S L. Transperitoneal transport of creatinine. A comparison of kinetic models. Clin Physiol 1994; 14: 443–57
  • Graff J, Fugleberg S, Joffe P, Fogh-Andersen N. Parameter estimation in six numerical models of transperitoneal transport of glucose. ASAIO J 1994; 40: 1005–11
  • Diaz-Buxo J A, Sulu W N. Automated peritoneal dialysis. The textbook of peritoneal dialysis, R Gokal, K D Nolph. Kluwer Academic, The Netherlands 1994; 399–418
  • Malluche H H. The possible use of bisphosphonates in the treatment of renal osteodystrophy. Clin Nephrol 1992; 38(1)S87–91
  • Fogelman I, Bessent R G, Turner J G, Citrin D L, Boyle I T, Greig W R. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 1978; 19: 270–5
  • Fogelman I, Bessent R G, Scullion J E, Cuthbert G F. Accuracy of 24-h whole-body (skeletal) retention of diphosphonate measurements. Eur J Nucl Med 1982; 7: 359–63
  • Henriksen J H. Degradation of bioactive substances: physiology and pathophysiology, J H Henriksen. CRC Press, Boca Raton, Florida 1991; 4–32
  • Christensen N J, Henriksen J H. Degradation of bioactive substances: physiology and pathophysiology, J H Henriksen. CRC Press, Boca Raton, Florida 1991; 290–305

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.